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Abstract Electropermeabilization/electroporation (EP) is
a physical method that by application of electric pulses to
cells increases cell membrane permeability and enables the
introduction of molecules into the cells. One of the uses of
EP in vivo is plasmid DNA electrotransfer to the skin for
DNA vaccination. EP of tissues induces reduction of blood
flow and, in combination with plasmid DNA, induction of
an immune response. One of the EP protocols for plasmid
DNA electrotransfer to the skin is a combination of high-
voltage (HV) and low-voltage (LV) pulses. However, the
effects of this pulse combination on skin-vessel blood flow
are not known. Therefore, using intravital microscopy in a
dorsal window chamber in mice and fluorescently labeled
dextrans, the effects of one HV and eight LV pulses on skin
vasculature were investigated. In addition, a detailed his-
tological analysis was performed. Image analysis of fluo-
rescence intensity changes demonstrated that EP induces a
transient constriction and increased permeability of blood
vessels as well as a ‘‘vascular lock.’’ Histological analysis
revealed rounding up of endothelial cells and stacking up
of erythrocytes at 1 h after EP. In addition, extravasation of
erythrocytes and leukocyte infiltration accompanied by
edema were determined up to 24 h after EP. In conclusion,
our results show that blood flow modifying effects of EP in
skin contribute to the infiltration of immune cells in the
exposed area. When combined with plasmid DNA for
vaccination, this could enable the initial and prolonged
contact of immune cells with encoded therapeutic proteins.
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Introduction
The use of plasmid DNA as a vaccine is a promising alter-
native to traditional vaccines that are based on live or atten-
uated viruses (Tang et al. 1992; Rice et al. 2008; Ingolotti et al.
2010; Ferraro et al. 2011). The possibility of delivering a
vaccine without inducing antiviral immunity, the ability to
formulate multicomponent vaccines (Hirao et al. 2011;
Sardesai and Weiner 2011), the stability of DNA at room
temperature and the safety of production compared to viral
vaccines make plasmid DNA vaccination especially attrac-
tive. Proper design of plasmid DNA can lead to enhanced
expression of antigen, targeted expression in the cell (cytosol
or endoplasmic reticulum) and induction of CD4? T-helper
cells, among other things, which leads to an increased immune
response (Rice et al. 2008). The initial problems with the
delivery of DNA vaccines to cells in vivo and induction of a
potent immune response of the host have been successfully
surmounted by using electropermeabilization/electroporation
(EP) as a delivery system (Drabick et al. 2001; Pavselj and
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Preat 2005; Rice et al. 2008; Donate et al. 2011; Sardesai and
Weiner 2011). EP is a physical method where the application
of external electric pulses directly to living cells induces a
local increase in transmembrane potential difference. This
consequently enables the introduction of molecules into the
cells (Miklavcic and Towhidi 2010). The method was first
described by Neumann et al. (1982) for the introduction of
DNA into cells in vitro; however, clinical use was first
achieved for the delivery of cancer chemotherapeutic drugs
with EP, such as bleomycin or cisplatin (electrochemothera-
py) (Marty et al. 2006; Sersa et al. 2008b). Nowadays, EP is
increasingly used for the delivery of different nucleic acids
(plasmid DNA, siRNA, miRNA, shRNA, etc.) into cells in
vitro and different tissues, including muscle, skin and tumors,
in vivo (Rols et al. 1998; Gehl and Mir 1999; Cemazar et al.
2006; Aung et al. 2009; Mir 2009; Escoffre et al. 2010; Vidic
et al. 2010). Effective use of EP for enhancement of plasmid
DNA vaccination was first reported 10 years ago (Kadowaki
et al. 2000; Widera et al. 2000; Drabick et al. 2001) and has
already reached the clinical trial stage (van Drunen Littel-van
den Hurk and Hannaman 2010; Ferraro et al. 2011; Vasan
et al. 2011; El-Kamary et al. 2012). The success of EP for
plasmid DNA vaccination was attributed to the fact that EP
enhances delivery of plasmid DNA into the cells, where it is
expressed for a long time (several months) (Widera et al. 2000;
Cemazar et al. 2006; Escoffre et al. 2010), and thus induces a
potent immune response of the host to the introduced encoded
antigen (Drabick et al. 2001; Liu et al. 2008; Roos et al. 2009;
Xing et al. 2012). Furthermore, EP was demonstrated to be
safe and well tolerated in preclinical as well as clinical studies
(Vanbever and Preat 1999; Sardesai and Weiner 2011;
El-Kamary et al. 2012).
The best results were obtained when plasmid DNA vacci-
nation was performed in muscle or skin (Sardesai and Weiner
2011). One of the EP protocols for plasmid DNA electro-
transfer used a combination of one short (100 ls) high-voltage
(HV) pulse and one or more long (several milliseconds) low-
voltage (LV) pulses, the voltage being chosen from the elec-
trode design and the tissue being pulsated. In this setting EP
increased DNA expression up to 100-fold in muscle and skin.
Also, a higher infiltration of immune cells into the EP area was
present, consequently enabling the contact of more antigen-
presenting cells (APCs) with encoded antigens (Roos et al.
2009; Tevz et al. 2009; Lee et al. 2011). It was shown that EP
induces vascular changes in muscle, which could contribute to
the observed immune effects (Gehl et al. 2002). However, the
vascular and blood-modifying effects of the HV–LV pulse
combination that was used for plasmid DNA electrotransfer to
the skin are not known.
Therefore, the aim of the present study was to determine
the effects of an HV–LV pulse combination on skin and
subcutaneous blood vessels. For this purpose we used in
vivo optical imaging in a dorsal window chamber (DWC)
(Jain et al. 2002; Dreher et al. 2006; Palmer et al. 2011) in
mice together with histological characteristic evaluation:
edema, blood-vessel changes and immune cell infiltration
at different times after the HV–LV pulse combination.
Materials and Methods
Reagents
We resuspended 2,000 kDa fluorescein isothiocyanate
(FITC) labeled dextran (Sigma-Aldrich, St. Louis, MO) in
phosphate-buffered saline (PBS). To remove any free FITC
or low-molecular weight contaminants, the 2,000 kDa
FITC-labeled dextran was washed two times for 2 h
through a 1,000 kDa Vivaspin ultrafiltration spin column
(Sartorius Stedim Biotech, Goettingen, Germany). The
high-molecular weight component was then resuspended in
PBS to a final concentration of 37.5 mg/ml.
Animals
In the experiments 6–8 week-old female C57Bl/6 mice
weighing 20–24 g were used. Mice were kept under spe-
cific pathogen-free conditions at a constant room temper-
ature (21 C) and humidity and a 12 h light/dark cycle.
Food and water were provided ad libitum. Animals were
subjected to an adaptation period of 14 days before
experiments. All animal experiments were conducted in
accordance with the guidelines for animal experiments of
the EU directives, the French procedural guidelines for
animal handling with the approval of the Regional Ethical
Review Committee in Midi-Pyre´ne´es (MP/02/36/10/10)
and permission from the Ministry of Agriculture, Forestry
and Food of the Republic of Slovenia (permission
34401-12/2009/6). For each experimental condition three
to five mice were randomly assigned, out of which two to
four mice were selected for histological analysis. Only one
experiment was performed on each mouse.
Preparation of the DWC in Mice
The DWC model in mice is a chronic model where a dorsal
skinfold is sandwiched between two symmetrical frames. It
allows direct visual access to the normal vasculature of the
skin through a standard microscopy cover glass and enables
repetitive high-resolution imaging of the exposed vasculature
in the same mouse over a period of 2–3 weeks (Palmer et al.
2011). For DWC implantation mice were first anesthetized
with an intraperitoneal injection of ketamine (1 mg/ml,
Narketan; Vetoquinol, Ittigen, Switzerland), xylazine
(5 mg/ml, Chanazine; Chanelle Pharmaceuticals, Loughrea,
Ireland) and acepromazine (0.4 mg/ml, Promace; Fort Dodge
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Animal Health, IA); then, the back of the mouse was shaved
and depilated with depilatory cream (Veet; Reckitt Benckiser,
Slough, UK). DWC (APJ Trading, Ventura, CA) consisting of
two titanium frames was surgically implanted onto the
extended double layer of the skin with stainless-steel screws
and sutures. Subsequently, one layer of the skin was excised to
expose the vasculature of the lower layer of skin. From the
lower layer of skin all fat and connective tissues were dis-
sected away to ensure optimal microscopic observation. The
DWC was filled with 0.9 % NaCl solution and closed with a
12 mm cover glass (Glaswarenfabrik Karl Hecht, Sondheim,
Germany). After the surgery and for the following 2 days,
butorphanol (0.3 mg/kg, Torbugesic; Fort Dodge Animal
Health) was injected intramuscularly once per day.
Electropermeabilization
EP was performed 3–7 days after the implantation of DWC
in mice. The pulsing parameters used were one HV pulse
(voltage-to-distance ratio 1,000 V/cm, duration 100 ls)
followed by a 1 s lag and eight LV pulses (voltage-to-dis-
tance ratio 140 V/cm, duration 50 ms, repetition frequency
1 Hz) (Andre et al. 2008). Pulses were generated by Clini-
porator
TM
(Igea, Carpi, Italy) and delivered by two parallel
stainless-steel rods (length 5 mm, width 1.3 mm) 4 mm
apart (Mazeres et al. 2009). The electrodes were placed on
the skin on the opposite side of the cover glass, where the
epidermis was intact. Good contact between the electrodes
and the skin was ensured by means of a conductive gel
(P. J. Dahlhausen, Cologne, Germany). To determine the
leakage of FITC-labeled dextran from the vessels, EP was
performed 2 min after FITC-labeled dextran injection, when
all vessels were completely filled, or at different times before
FITC-labeled dextran injection to determine resealing of the
vessel wall and duration of the ‘‘vascular lock.’’
Intravital Microscopy and Image Acquisition
For intravital microscopy an upright ‘‘Macrofluo’’ fluores-
cence microscope (Leica Microsystems, Rueil-Malmaison,
France) equipped with a Cool Snap HQ Camera (Roper
Scientific, Ottobrunn, Germany) and Metamorph (Molecular
Devices, Sunnyvale, CA) image acquisition software were
used. Animals were first anesthetized with inhalation anes-
thesia (Isofluran; Nicholas Piramal India, London, UK) and
placed on a custom-designed holder, which enabled fixation of
the DWC during image acquisition and therefore prevented
the artifacts caused by movement due to breathing. Blood
vessels were visualized by fluorescence (excitation filter, BP
480/40 nm; emission filter, LP 510 nm) after injection of
100 ll of FITC-labeled dextran (3.75 mg/mouse). To ensure
that the vessels were completely filled up, a series of images
every 20 s for 2 min was acquired when FITC-labeled dextran
was injected before EP. Immediately after EP (\10 s) a sec-
ond series of images every 20 s for the first 8 min and every
2 min for the next 22 min was acquired. When FITC-labeled
dextran was injected after EP, only the second series of images
was acquired. Images were analyzed offline with image
analysis software (AxioVision; Zeiss, Jena, Germany).
Data Analysis
To determine the increase in fluorescence intensity inside
and outside the vessels, a differential approach was used,
which was adapted from Reyes-Aldasoro et al. (2008), fol-
lowed by specific image analysis. Briefly, after i.v. injection
of FITC-labeled dextran, a series of images was acquired
during the first 2 min before EP and 30 min after EP. Then, a
mask of the blood-vessel network was created and the mean
fluorescence intensity determined in the vascular compart-
ment and in the tissue. For measurement of blood-vessel
diameters, at least five venules (diameters 20–250 lm) and
arterioles (10–100 lm) were selected from each mouse. The
narrow, straight, fast-flowing vessels with few branches were
defined as arterioles and the rest as venules. The diameter of
the vessels was measured in each image of the recorded
series and normalized to the value before EP.
Histology
The circular part of the skin inside the DWC that was
monitored through the cover glass was excised at 1, 12, 24,
or 48 h after EP. The skin was then fixed in formalin for
24 h and stored in 70 % ethanol until it was embedded in
paraffin in such orientation that sections were cut perpen-
dicular to the skin layers encompassing both parts of the
skin where electrodes were placed. From each DWC
preparation, 9–12 sections of 5 lm thickness were cut and
stained with hematoxylin and eosin. Slides were observed
with a BX-51 microscope (Olympus, Hamburg, Germany)
coupled with a DP72 digital camera (Olympus).
Statistical Analysis
For statistical analysis Sigma Plot software (Systat Software,
London, UK) was used. For comparison of the control and EP
groups, a Student t-test or one-way ANOVA followed by a
Holm-Sidak test was used. A value of p \ 0.05 was con-
sidered statistically significant.
Results
EP Induces Constriction of Blood Vessels
To determine the effect of EP on vessel morphology, the
diameters of arterioles and venules were measured for the
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first 30 min after EP. Application of electric pulses resulted
in an immediate constriction of the arterioles and venules
(Fig. 1). The statistically significant constriction of arteri-
oles (*70 %) was more pronounced than the constriction
of venules (*30 %) and lasted longer (Fig. 1). In com-
parison to the control, the diameters of arterioles remained
statistically significantly smaller during the entire
observation period (30 min), whereas the diameters of
venules returned to pre-EP values 14 min after EP (Fig. 1).
The diameters of arterioles and venules in control mice
remained constant during the entire observation time
(20–250 lm for venules and 10–100 lm for arterioles).
EP Induces a ‘‘Vascular Lock’’
EP induced transient obstruction of blood flow, a ‘‘vascular
lock’’ in the skin, which resulted in slowed filling up of
vessels in comparison to the control group, where complete
filling up of vessels was achieved within 2 min after FITC-
labeled dextran i.v. injection (Fig. 2a). When FITC-labeled
dextran was injected 0.5, 1, and 5 min after EP, the filling
up of all pulsed vessels was completed *10 min after i.v.
injection (Figs. 2,3). When FITC-labeled dextran was
injected 10 or 30 min after EP, the filling up of vessels was
completed within 3 min after i.v. injection (Fig. 2). The
maximal variation of mean fluorescence intensity per sec-
ond was also statistically significantly decreased at 0.5, 1,
and 5 min after EP (Fig. 2b). This demonstrates that the
EP-induced ‘‘vascular lock’’ in the skin is transient and
lasts *10 min after EP.
EP Increases the Permeability of Blood Vessels
To determine the effect of EP on the permeability of blood
vessels, the relative variation of the mean fluorescence
intensity in the tissue neighboring the blood vessel due to
FITC-labeled dextran leakage from the pulsed blood ves-
sels was measured (Fig. 3). A statistically significant
increase of the mean fluorescence intensity was determined
after EP in comparison to the control. For the first 8 min
Fig. 1 Constriction of blood vessels after EP. Diameters of vessels
were measured after i.v. injection of FITC-labeled dextran. Pulsing
parameters when EP was applied: one pulse of voltage-to-distance
ratio 1,000 V/cm, 100 ls, 1s pause; eight pulses of voltage-to-
distance ratio 140 V/cm, 50 ms, 1 Hz. Diameters were normalized to
the value 2 min after i.v. injection of FITC-labeled dextran.
Normalized diameters of arterioles and venules after EP (n = 3) are
represented as a function of time in comparison to control (n = 3).
Diameters were statistically significantly smaller for the first 14 min
for venules and throughout the observation time for arterioles
(p \ 0.05). Student’s t test was used for comparison of each time
point of the EP group to the same time point of the control group
Fig. 2 Time course of filling up of blood vessels after EP. Kinetics of
filling up of vessels was determined after i.v. injection of FITC-
labeled dextran at different times after EP (0.5, 1, 5, 10, and 30 min).
Pulsing parameters when EP was applied: one pulse of voltage-to-
distance ratio 1,000 V/cm, 100 ls, 1s pause; eight pulses of voltage-
to-distance ratio 140 V/cm, 50 ms, 1 Hz. a Filling up of vessels is
expressed as a percent of maximum mean fluorescence intensity in
vessels (Imax) after i.v. injection of FITC-labeled dextran. b Maximal
variation of intensity per second calculated from the filling up curves.
The filling up of vessels was slowed down when dextran was i.v.
injected 0.5, 1, and 5 min after EP and returned to control levels when
the interval between EP and i.v. -injection was 10 and 30 min
(n = 3–5). A one-way ANOVA followed by a Holm-Sidak test were
used for statistical analysis. *p \ 0.05 in comparison to the control.
Error bars indicate SEM
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after EP, the increase of relative variation of fluorescence
intensity was linearly dependent on time, after which it
reached a plateau (Fig. 4a). In the control group the relative
variation of mean fluorescence intensity in the tissue
decreased slightly during the observation time (Fig. 4a).
To evaluate the duration of increased permeability of the
pulsed blood vessels, FITC-labeled dextran was i.v.-injec-
ted at different times after EP and the relative increase of
mean fluorescence in the tissue per minute was determined
thereafter (Figs. 3, 4b). Statistically significant values were
determined for the injection of FITC-labeled dextran 0.5, 1,
and 5 min after EP; then, the relative variation of mean
fluorescence intensity per minute decreased and reached
values similar to the control group when injection of FITC-
labeled dextran was performed 30 min after EP (Fig. 4b).
For the calculations, only the first 8 min after FITC-labeled
dextran injection were relevant due to the fact that during
this time interval after EP the FITC-labeled dextran leak-
age from blood vessels into the tissue was linearly
dependent on time (Fig. 4a).
Fig. 3 Illustration of ‘‘vascular lock’’ and dextran leakage into the
tissue after EP. Pulsing parameters when EP was applied: one pulse of
voltage-to-distance ratio 1,000 V/cm, 100 ls, 1s pause; eight pulses
of voltage-to-distance ratio 140 V/cm, 50 ms, 1 Hz. ‘‘Vascular lock’’
was determined when FITC-labeled dextran was i.v. -injected 0.5 min
after EP (EP ? 30 s), where the filling up of vessels was completed
*10 min after EP, whereas leakage of FITC-labeled dextran was
observed earlier (*6 min after EP). Leakage of FITC-labeled dex-
tran into the tissue was measured when FITC-labeled dextran was
i.v. -injected 2 min before EP (EP), and then relative variation of
mean fluorescence intensity was determined for the next 30 min. In
the control group (Control) filling up of vessels was completed within
2 min after i.v. injection of FITC-labeled dextran, and there was no
leakage of dextran into the tissue
Fig. 4 Increased permeability of blood vessels and duration of
increased permeability. Pulsing parameters when EP was applied: one
pulse of voltage-to-distance ratio 1,000 V/cm, 100 ls, 1s pause; eight
pulses of voltage-to-distance ratio 140 V/cm, 50 ms, 1 Hz. a Measure
of relative mean fluorescence intensity changes in DWC tissues
outside the vessels as a function of time after EP in comparison to the
control group without EP. b Measure of relative mean fluorescence
intensity changes per minute in DWC tissues outside the vessels when
FITC-labeled dextran was injected at different times after EP
(n = 3–5). A one-way ANOVA followed by a Holm-Sidak test were
used for statistical analysis. *p \ 0.05 in comparison to control. Error
bars indicate SEM
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EP-Induced Histological Changes of the Skin
Histological changes of the skin after EP were determined
1, 12, 24, and 48 h after EP. In the slides, sections of the
skin consisting of epidermis, dermis with hair follicles,
subcutaneous tissues with blood vessels and a thin striated
muscle layer are presented (Fig. 5a). Rounding up of vessel
endothelial cells, narrowing of vessel lumen and stacking
of erythrocytes in vessels were present at 1 h after EP
(Fig. 5d–f) but were not present anymore at later time
points. The extravasation of erythrocytes; increased pres-
ence and marginalization of leukocytes, which was
accompanied by extravasation; and increased infiltration of
leukocytes into the tissue between the electrodes was
observed at 1 and 12 h after EP (Fig. 5d–i). Infiltration of
leukocytes was also observed at 24 h after EP, which
decreased at 48 h after EP (Fig. 5j–o). Infiltration was
accompanied by edema, which was present in the con-
nective tissue under the epidermis at all time points, except
at 48 h after EP, when it was already resolved (Fig. 5). All
of these features were more pronounced closer to the
negative electrode than under the positive one or between
the electrodes. In addition, at all time points the damage to
the epidermis, vessels and hair follicles was much more
evident under the negative electrode, where even destruc-
tion of different tissue structures was observed (Fig. 5).
Recovery of the epidermis and underlying tissue under the
electrodes was evident at 24 and 48 h after EP (Fig. 5g–o).
All of the above-mentioned features were observed in all
samples at specific time points.
Discussion
The results of this study show that application of an
HV–LV pulse combination used for plasmid DNA elec-
trotransfer to the skin induces a transient constriction of
blood vessels, ‘‘vascular lock’’ and increased permeability
of blood vessels. Already within 1 h after EP rounding up
of endothelial cells and stacking up of erythrocytes can be
observed in the area of the tissue exposed to EP. In addi-
tion, extravasation of erythrocytes into the tissue and leu-
kocyte infiltration with edema were observed. Damage to
the epidermis and the tissue beneath the electrodes was
repaired within 48 h after EP.
Several studies have reported that different HV–LV
combinations of pulses are very effective for plasmid DNA
electrotransfer to the skin, inducing a better immune
response and longer gene expression in comparison to HV
or LV pulses alone (Pavselj and Preat 2005; Andre et al.
2008; Roos et al. 2009; Brave et al. 2010; Gothelf et al.
2011). Concerning the safety of the methods, regardless of
the electrodes used, the application of pulses to the skin
results in a slight and transient disruption of the skin barrier
function, slight and transient erythema and upregulation of
genes involved in the immune response (Dujardin et al.
2002; Pavselj and Preat 2005; Roos et al. 2009). However,
there have been no reports on the effects of EP on the
vasculature of the skin and detailed histological analysis of
these effects. Our study is the first to provide direct
observations of the effects of an HV–LV combination of
pulses on normal vasculature in the skin.
First, the effects of EP on blood vessels in the skin from
our direct observation extended the models of vascular
response observed in studies done on muscle and tumors
(Gehl et al. 2002; Sersa et al. 2008a). The vascular response
was described as a two-phase phenomenon, where the first
short phase is quick and was attributed to sympathetically
mediated vasoconstriction of afferent arterioles, whereas the
second slower phase is of much longer duration (up to
30 min in the case of muscle) and supposed to follow the
kinetics of cell membrane resealing after EP and changes of
endothelial cell shape (Gehl et al. 2002; Jarm et al. 2010).
Our data on measurement of blood-vessel diameters are in
agreement with this hypothesis. The immediate constriction
of blood vessels after EP was more pronounced for arterioles
(*70 %) than for venules (*30 %). The constriction of
arterioles also lasted longer (throughout the observation
period) than the constriction of venules (*15 min). The
bigger impact of EP on the diameter of arterioles can be
explained by differences in the structure of the blood-vessel
wall, where the smooth muscle of the tunica media is more
abundant in the wall of arterioles compared to venules
(Seeley et al. 2000). The observed constriction of the blood
vessels resulted in a ‘‘vascular lock’’ (Gehl et al. 2002; Sersa
et al. 2008a) (Fig. 2). The filling up of the vessels was sta-
tistically significantly slower for the first 5 min after EP. For
example, when FITC-labeled dextran was injected imme-
diately after EP (0.5 min), the filling up of the blood vessels
Fig. 5 EP-induced changes in skin. Representative images of tissue
sections which were exposed to EP and stained with hematoxylin and
eosin (pulsing parameters: one pulse of voltage-to-distance ratio
1,000 V/cm, 100 ls, 1s pause; eight pulses of voltage-to-distance
ratio 140 V/cm, 50 ms, 1 Hz). a E epidermis, D dermis with hair
follicles, S subcutaneous tissues with blood vessels, M a thin striated
muscle layer; b arrow blood vessels; c arrow intact epidermis,
arrowhead hair follicle; d arrow stacking of erythrocytes; e arrow
rounding up of endothelial cells in the venule, arrowhead rounding up
of endothelial cells in the arteriole; f thick arrow damaged keratino-
cytes under the electrode, arrowhead marginalization of immune cells
(prominent nuclei are present) in the blood vessel, thin arrow
damaged hair follicle; g arrow extravasation of erythrocytes; h arrow
infiltration of immune cells; i arrow damaged keratinocytes under the
electrode, arrowhead damaged hair follicle; j arrow edema; k arrow
infiltration of immune cells; l arrow recovery of epidermis, arrow-
head damaged keratinocytes under the electrode; m arrow recovered/
normal blood vessels; n arrow infiltration of immune cells; o arrow
recovery of epidermis, arrowhead damaged keratinocytes under the
electrode. Scale bar 50 lm
c
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was completed *10 min after the injection. Direct in vivo
experimental support for the second phase of the proposed
vascular effects was demonstrated in our study by increased
permeability of the blood vessels after EP for 2,000 kDa
FITC-labeled dextran. Its size was chosen as being approx-
imately the size of plasmid DNA (Paganin-Gioanni et al.
2011). The increased permeability of the blood vessels for
2,000 kDa FITC-labeled dextran lasted for 5–10 min and
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gradually returned to pre-EP values 30 min after EP. The
second phase was mainly attributed to disruption of the
cellular cytoskeleton and junctional integrity of the blood-
vessel endothelium (Kanthou et al. 2006; Jarm et al. 2010).
The increased permeability of the blood vessels for
2,000 kDa FITC-labeled dextran returned to control levels
only 30 min after EP, indicating that restoration of the blood-
vessel endothelium is slow and, thus, enables leakage of
large molecules for an extended period of time.
Second, EP also has other effects on the target tissue
besides vascular effects, and very little is known about
these effects. It is now known that application of electric
pulses to tissues affects not only the permeability of cell
membranes but also the distribution of DNA and other
molecules in the tissues (Zaharoff et al. 2002; Henshaw
et al. 2007, 2011). One of the hallmarks of DNA vacci-
nation combined with EP is that EP significantly enhances
the immunogenicity of DNA vaccines relative to DNA
injection alone also in human clinical trials (Hirao et al.
2010; Livingston et al. 2010; Sardesai and Weiner 2011;
Vasan et al. 2011). This was concluded by measuring
different features of the immune response, but the under-
lying mechanisms remain poorly understood. DNA vacci-
nation, regardless of the therapeutic gene used, combined
with EP increased the excretion of interferon-gamma from
antigen-specific CD8? cells, increased the number of
antigen-specific CD4? cells and several other types of
immune cells compared to injection of DNA alone or
another type of vaccination (Rosati et al. 2009; Belisle
et al. 2011; Brave et al. 2011; Kulkarni et al. 2011; Lee
et al. 2011; Sardesai and Weiner 2011). The results of our
study demonstrate that the effects of EP on skin blood
vessels can contribute to the immune response observed in
other studies when EP was combined with DNA vaccines.
Namely, the observed effects of EP, i.e., increased per-
meability of blood vessels and ‘‘vascular lock,’’ cause a
small and reversible tissue damage that is enough to lead to
inflammation and increased infiltration of immune cells.
Specifically, EP induces increased permeability of the
blood vessels for at least 30 min, which enables protein
leakage outside the vessels, leading to a decrease in the
pressure between the intra- and extra-vascular compart-
ments and to extravasation of fluids. The results are
development of interstitial edema, increased interstitial
fluid pressure and decreased intravascular pressure, which
all contribute to compromised blood flow, i.e. ‘‘vascular
lock,’’ in addition to vasoconstriction. Furthermore,
although the observed ‘‘vascular lock’’ was short-lived, it
can still result in ischemia–reperfusion injury (van den
Heuvel et al. 2009). Moreover, it was shown in our pre-
vious studies that EP causes the formation of reactive
oxygen species in vitro, which was indirectly shown also in
vivo in mouse muscle (Gabriel and Teissie 1995; Markelc
et al. 2012). All of these effects of EP on skin and sub-
cutaneous vasculature observed by in vivo imaging were
confirmed by histological analysis performed at different
times after EP. Increased permeability of the blood vessels
was demonstrated by rounding up of endothelial cells,
extravasation of erythrocytes and edema present in the
connective tissue below the epidermis. Furthermore,
attraction of immune cells was demonstrated by the mar-
ginalization of leukocytes in the vessels and by pronounced
infiltration seen only in the areas between the electrodes,
which were present for at least 24 h. Therefore, taken
collectively, in case of plasmid DNA vaccine combined
with EP, we can predict that the cells transfected with
plasmid DNA are in contact with numerous immune cells
for at least 24 h. Thus, the plasmid DNA has enough time
to translate into an antigenic protein, which can react with
immune cells, leading to a pronounced immune response,
both cellular and humoral. It is also worth mentioning that
the effects of EP on histological changes (tissue damage,
lymphocyte infiltration, etc.) were more pronounced at the
negative electrode. The reason for this observation is not
known, but it could be ascribed to the electrolytic chemical
reaction of reduction at the negative electrode, leading to
formation of different chemicals, mainly sodium hydroxide
(Wagner et al. 1985).
One of the aspects dealing with translation of plasmid
DNA vaccination combined with EP to more widespread
use in humans is the standardization of EP parameters.
From the tissue effects of EP that were shown in previous
studies in muscle, tumors and our study on the skin, it is
obvious that the EP parameters optimized for therapeutic
effects are dependent on the tissue’s structural character-
istics and blood-vessel morphology. Therefore, further
studies are needed to evaluate the tissue effect of EP, which
will bring plasmid DNA vaccination combined with EP
into wider clinical use.
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